• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Heart failure and cardiomyopathy are significant contributors to pregnancy-related deaths,
as maternal morbidity and mortality have been increasing over time. In this setting, the role …

Background We aimed to assess the association between number of pregnancies and long‐
term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with …

Over the last years, there has been a growing interest in the clinical manifestations and
outcomes of cardiomyopathies in women. Peripartum cardiomyopathy is the only women …

Background: In the last few years, a phenotypic variant of arrhythmogenic cardiomyopathy
(ACM) labeled arrhythmogenic left ventricular cardiomyopathy (ALVC) has been defined …

Arrhythmogenic cardiomyopathy (AC) is a rare heart muscle disease with a genetic
background and autosomal dominant mode of transmission. The clinical manifestation is …

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiac disease
explaining about 4% of sudden cardiac death (SCD) cases in the young in Sweden. This …

A sensation of abnormal or irregular heart beating is a very common symptom in pregnancy.
This is often secondary to sinus tachycardia, sinus bradycardia and sinus arrhythmia, or …

Genetic cardiomyopathies are hereditary cardiac diseases often diagnosed in young
patients and are characterized by live-threatening arrhythmias and heart failure. Among …

Pregnancy is not contraindicated and generally safe in women with IA. Vaginal delivery is
generally well tolerated and operative delivery should be reserved to patients with heart …